Frank R. Lichtenberg

Columbia University - Columbia Business School, Finance

Courtney C. Brown Professor of Business

3022 Broadway

504 Uris Hall, Dept. of Finance & Economics

New York, NY 10027

United States

http://https://www8.gsb.columbia.edu/cbs-directory/detail/frl1

National Bureau of Economic Research (NBER)

1050 Massachusetts Avenue

Cambridge, MA 02138

United States

CESifo (Center for Economic Studies and Ifo Institute for Economic Research)

Poschinger Str. 5

Munich, DE-81679

Germany

SCHOLARLY PAPERS

76

DOWNLOADS
Rank 11,594

SSRN RANKINGS

Top 11,594

in Total Papers Downloads

6,256

SSRN CITATIONS
Rank 2,130

SSRN RANKINGS

Top 2,130

in Total Papers Citations

73

CROSSREF CITATIONS

527

Scholarly Papers (76)

Pharmaceutical Price Discrimination and Social Welfare

Capitalism and Society, Vol. 5, Issue 1, Article 2, 2010
Number of pages: 32 Posted: 29 Jan 2013
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 350 (125,503)
Citation 1

Abstract:

Loading...

Pharmaceutical Price Discrimination and Social Welfare

Capitalism and Society, Vol. 5, No. 1, p. 2, 2010
Number of pages: 32 Posted: 26 Oct 2011
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 103 (373,516)

Abstract:

Loading...

The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey

Number of pages: 27 Posted: 15 Mar 2001
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 262 (170,131)

Abstract:

Loading...

The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey

NBER Working Paper No. w8147
Number of pages: 27 Posted: 08 Mar 2001 Last Revised: 10 Oct 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 180 (242,027)

Abstract:

Loading...

3.
Downloads 411 (105,467)
Citation 4

Sources of U.S. Longevity Increase, 1960 - 1997

Number of pages: 33 Posted: 21 Mar 2001
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 326 (135,645)

Abstract:

Loading...

Sources of U.S. Longevity Increase, 1960-1997

NBER Working Paper No. w8755
Number of pages: 32 Posted: 02 Feb 2002 Last Revised: 05 Jun 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 85 (422,763)
Citation 1

Abstract:

Loading...

The Effects of Mergers on Prices, Costs, and Capacity Utilization in the U.S. Air Transportation Industry, 1970-84

The Jerome Levy Economics Institute Working Paper No. 32
Number of pages: 22 Posted: 27 Oct 1999
Frank R. Lichtenberg and Moshe Kim
Columbia University - Columbia Business School, Finance and University of Haifa - Department of Economics
Downloads 363 (120,511)

Abstract:

Loading...

The Effects of Mergers on Prices, Costs, and Capacity Utilization in the U.S. Air Transportation Industry, 1970-84

NBER Working Paper No. w3197
Number of pages: 22 Posted: 08 Jul 2004 Last Revised: 28 Sep 2022
Frank R. Lichtenberg and Moshe Kim
Columbia University - Columbia Business School, Finance and University of Haifa - Department of Economics
Downloads 39 (617,778)

Abstract:

Loading...

5.

Is Home Health Care a Substitute for Hospital Care?

Number of pages: 25 Posted: 23 Jan 2011
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 310 (143,784)

Abstract:

Loading...

home health care, hospitals, length of stay

6.

Benefits and Costs of Newer Drugs: An Update

NBER Working Paper No. w8996
Number of pages: 13 Posted: 13 Jun 2002 Last Revised: 01 Aug 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 222 (200,455)

Abstract:

Loading...

Industrial De-Diversification and its Consequences for Productivity

Jerome Levy Economics Institute Working Paper No. 35
Number of pages: 42 Posted: 15 Mar 2000
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 188 (232,911)

Abstract:

Loading...

Industrial De-Diversification and its Consequences for Productivity

NBER Working Paper No. w3231
Number of pages: 42 Posted: 09 Oct 2007 Last Revised: 31 Oct 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 23 (733,081)

Abstract:

Loading...

8.

The Effects of Leveraged Buyouts on Productivity and Related Aspects of Firm Behavior

NBER Working Paper No. w3022
Number of pages: 55 Posted: 08 Jul 2004 Last Revised: 06 Oct 2022
Frank R. Lichtenberg and Donald S. Siegel
Columbia University - Columbia Business School, Finance and Arizona State University-School of Public Affairs
Downloads 192 (228,855)
Citation 18

Abstract:

Loading...

9.

The Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France

CESifo Working Paper Series No. 3095
Number of pages: 45 Posted: 27 Jun 2010
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 170 (254,014)

Abstract:

Loading...

10.

The Impact of New Drug Launches on Longevity: Evidence from Longitudinal Disease-Level Data from 52 Countries, 1982-2001

NBER Working Paper No. w9754
Number of pages: 37 Posted: 08 Jun 2003 Last Revised: 28 Aug 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 167 (257,908)
Citation 2

Abstract:

Loading...

11.

Does Misery Love Company? Evidence from Pharmaceutical Markets Before and after the Orphan Drug Act

NBER Working Paper No. w9750
Number of pages: 31 Posted: 09 Jun 2003 Last Revised: 24 Aug 2022
Frank R. Lichtenberg and Joel Waldfogel
Columbia University - Columbia Business School, Finance and University of Minnesota - Twin Cities - Carlson School of Management
Downloads 131 (312,998)
Citation 2

Abstract:

Loading...

12.

The Impact of Pharmaceutical Innovation on Longevity and Medical Expenditure in Sweden, 1997-2010: Evidence from Longitudinal, Disease-Level Data

CESifo Working Paper Series No. 3894
Number of pages: 43 Posted: 22 Aug 2012
Frank R. Lichtenberg and Billie Pettersson
Columbia University - Columbia Business School, Finance and affiliation not provided to SSRN
Downloads 130 (314,774)
Citation 1

Abstract:

Loading...

longevity, pharmaceutical, innovation, drugs, Sweden

13.
Downloads 122 (329,823)
Citation 2

The Allocation of Publicly-Funded Biomedical Research

CES No. 140
Number of pages: 29 Posted: 09 Dec 1997
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 86 (419,651)
Citation 2

Abstract:

Loading...

The Allocation of Publicly-Funded Biomedical Research

NBER Working Paper No. w6601
Number of pages: 30 Posted: 29 Jun 2000 Last Revised: 17 Jul 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 36 (636,121)

Abstract:

Loading...

14.

Pharmaceutical Innovation, Mortality Reduction, and Economic Growth

NBER Working Paper No. w6569
Number of pages: 30 Posted: 24 May 1999 Last Revised: 15 Jun 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 119 (337,772)

Abstract:

Loading...

15.

Ownership Structure and Corporate Performance in Japan

NBER Working Paper No. w4092
Number of pages: 41 Posted: 22 Jun 2004 Last Revised: 04 Apr 2022
Frank R. Lichtenberg and George Pushner
Columbia University - Columbia Business School, Finance and Columbia University - Columbia Business School
Downloads 116 (341,826)

Abstract:

Loading...

16.

The Impact of New (Orphan) Drug Approvals on Premature Mortality from Rare Diseases in the U.S. and France, 1999-2007

Number of pages: 27 Posted: 11 Jan 2011
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 109 (356,885)

Abstract:

Loading...

orphan drugs, rare diseases, mortality, innovation

17.

The Expanding Pharmaceutical Arsenal in the War on Cancer

NBER Working Paper No. w10328
Number of pages: 50 Posted: 09 Mar 2004 Last Revised: 22 Sep 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 106 (363,740)

Abstract:

Loading...

18.

Has Medical Innovation Reduced Cancer Mortality?

NBER Working Paper No. w15880
Number of pages: 48 Posted: 12 Apr 2010 Last Revised: 23 Nov 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 105 (366,038)
Citation 1

Abstract:

Loading...

19.

Spurious Correlation in Estimation of the Health Production Function: A Note

KOF Working Papers No. 227
Number of pages: 15 Posted: 18 May 2009
Sule Akkoyunlu, Frank R. Lichtenberg, Boriss Siliverstovs and Peter Zweifel
ETH Zürich - KOF Swiss Economic Institute, Columbia University - Columbia Business School, Finance, German Institute for Economic Research (DIW Berlin) - Department of International Economics and University of Zurich - Department of Economics
Downloads 101 (375,557)
Citation 4

Abstract:

Loading...

health, life expectancy, innovation, pharmaceuticals, health care expenditure, cointegration

20.

International R&D Spillovers: A Re-Examination

NBER Working Paper No. w5668
Number of pages: 25 Posted: 15 Sep 2000 Last Revised: 29 Jun 2022
Frank R. Lichtenberg and Bruno van Pottelsberghe de la Potterie
Columbia University - Columbia Business School, Finance and Free University of Brussels - Solvay Business School
Downloads 99 (380,498)

Abstract:

Loading...

21.

Despite Steep Costs, Payments for New Cancer Drugs Make Economic Sense

Nature Medicine, Vol. 17, No. 244, 2011
Number of pages: 2 Posted: 26 Oct 2011
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 93 (395,829)

Abstract:

Loading...

22.

R&D Investment and International Productivity Differences

NBER Working Paper No. w4161
Number of pages: 39 Posted: 14 Jul 2000 Last Revised: 16 Nov 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 92 (398,559)
Citation 1

Abstract:

Loading...

23.

Pharmaceutical-Embodied Technical Progress, Longevity, and Quality of Life: Drugs as "Equipment for Your Health"

NBER Working Paper No. w9351
Number of pages: 44 Posted: 21 Nov 2002 Last Revised: 22 Jul 2022
Frank R. Lichtenberg and Suchin Virabhak
Columbia University - Columbia Business School, Finance and affiliation not provided to SSRN
Downloads 86 (415,497)
Citation 5

Abstract:

Loading...

24.

The Effect of Pharmaceutical Utilization and Innovation on Hospitalization and Mortality

NBER Working Paper No. w5418
Number of pages: 35 Posted: 22 Jun 2000 Last Revised: 26 Oct 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 86 (415,497)

Abstract:

Loading...

25.

The Impact of R&D Investment on Productivity - New Evidence Using Linked R&D-Lrd Data

NBER Working Paper No. w2901
Number of pages: 46 Posted: 16 Jul 2004 Last Revised: 06 Jun 2022
Frank R. Lichtenberg and Donald S. Siegel
Columbia University - Columbia Business School, Finance and Arizona State University-School of Public Affairs
Downloads 80 (433,535)
Citation 4

Abstract:

Loading...

26.

R and D and Productivity at the Industry Level: Is There Still a Relationship?

NBER Working Paper No. w0850
Number of pages: 52 Posted: 14 Jul 2000 Last Revised: 30 Oct 2022
Zvi Griliches and Frank R. Lichtenberg
(Deceased) and Columbia University - Columbia Business School, Finance
Downloads 73 (456,359)
Citation 1

Abstract:

Loading...

27.

The Impact of Hospital Quality-Related Practices on Health Outcomes

Syracuse University Center for Policy Research Working Paper No. 18
Number of pages: 24 Posted: 13 Apr 2011
Deborah Freund and Frank R. Lichtenberg
Claremont Colleges - Claremont Graduate University and Columbia University - Columbia Business School, Finance
Downloads 68 (473,892)
Citation 1

Abstract:

Loading...

The Effect of Drug Vintage on Survival: Micro Evidence from Puerto Rico's Medicaid Program

NBER Working Paper No. w10884
Number of pages: 24 Posted: 14 Nov 2004 Last Revised: 29 Sep 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 50 (558,096)

Abstract:

Loading...

The Effect of Drug Vintage on Survival: Micro Evidence from Puerto Rico's Medicaid Program

Advances in Health Economics and Health Services Research, Vol. 22, pp. 273-292, 2010
Number of pages: 24 Posted: 26 Oct 2011
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 17 (787,859)

Abstract:

Loading...

The Dual Effects of Intellectual Property Regulations: Within- and Between- Patent Competition in the Us Pharmaceuticals Industry

NBER Working Paper No. w9303
Number of pages: 40 Posted: 07 Nov 2002 Last Revised: 04 Jun 2022
Frank R. Lichtenberg and Tomas Philipson
Columbia University - Columbia Business School, Finance and University of Chicago
Downloads 65 (491,902)
Citation 2

Abstract:

Loading...

The Dual Effects of Intellectual Property Regulations: Within- and Between-Patent Competition in the Us Pharmaceuticals Industry

Journal of Law & Economics, Vol. 45, pp. 643-672, 2002
Posted: 11 Sep 2003
Frank R. Lichtenberg and Tomas Philipson
Columbia University - Columbia Business School, Finance and University of Chicago

Abstract:

Loading...

30.

Training, Tenure, and Productivity

NBER Working Paper No. w0671
Number of pages: 42 Posted: 01 Mar 2001 Last Revised: 03 Nov 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 64 (488,878)

Abstract:

Loading...

31.

Pharmaceutical Innovation and Longevity Growth in 30 Developing and High-Income Countries, 2000-2009

NBER Working Paper No. w18235
Number of pages: 49 Posted: 21 Jul 2012 Last Revised: 30 Oct 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 63 (492,843)
Citation 2

Abstract:

Loading...

32.

Pharmaceuticai Innovation, Longevity, and Medical Expenditure in Greece, 1995-2010

CESifo Working Paper Series No. 5166
Number of pages: 34 Posted: 04 Feb 2015
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 60 (504,654)

Abstract:

Loading...

pharmaceutical, innovation, longevity, Greece, hospital

33.

The Quality of Medical Care, Behavioral Risk Factors, and Longevity Growth

NBER Working Paper No. w15068
Number of pages: 58 Posted: 16 Jun 2009 Last Revised: 04 Sep 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 59 (508,622)
Citation 2

Abstract:

Loading...

34.

The Effect of Changes in Drug Utilization on Labor Supply and Per Capita Output

NBER Working Paper No. w9139
Number of pages: 46 Posted: 06 Sep 2002 Last Revised: 23 Jun 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 58 (512,714)

Abstract:

Loading...

35.

The Impact of New Laboratory Procedures and Other Medical Innovations on the Health of Americans, 1990-2003: Evidence from Longitudinal, Disease-Level Data

NBER Working Paper No. w12120
Number of pages: 25 Posted: 15 May 2006 Last Revised: 13 Feb 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 57 (516,833)

Abstract:

Loading...

36.

The Output Contributions of Computer Equipment and Personnel: A Firm- Level Analysis

NBER Working Paper No. w4540
Number of pages: 45 Posted: 19 Mar 2001 Last Revised: 29 Nov 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 54 (529,707)
Citation 6

Abstract:

Loading...

37.

Response to Baker and Fugh-Berman’s Critique of My Paper, 'Why Has Longevity Increased More in Some States than in Others?'

Number of pages: 11 Posted: 09 Jul 2009
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 52 (538,604)

Abstract:

Loading...

longevity, innovation, pharmaceuticals, obesity

38.

The Effect of New Drugs on Mortality from Rare Diseases and HIV

NBER Working Paper No. w8677
Number of pages: 27 Posted: 20 Dec 2001 Last Revised: 18 Sep 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 52 (538,604)

Abstract:

Loading...

39.

Computer Use and Productivity Growth in Federal Government Agencies, 1987 to 1992

NBER Working Paper No. w5616
Number of pages: 34 Posted: 29 Apr 1998 Last Revised: 08 May 2022
William Lehr and Frank R. Lichtenberg
Massachusetts Institute of Technology (MIT) - Computer Science and Artificial Intelligence Laboratory (CSAIL) and Columbia University - Columbia Business School, Finance
Downloads 52 (538,604)

Abstract:

Loading...

40.

The Impact of Recent Chemotherapy Innovation on the Longevity of Myeloma Patients: U.S. and International Evidence

CESifo Working Paper Series No. 4516
Number of pages: 32 Posted: 24 Dec 2013
Frank R. Lichtenberg and Gisela Hostenkamp
Columbia University - Columbia Business School, Finance and University of Southern Denmark
Downloads 50 (547,791)

Abstract:

Loading...

41.

The Impact of New Drug Launches on Hospitalization in 2015 for 67 Medical Conditions in 15 OECD Countries: A Two-Way Fixed-Effects Analysis

CESifo Working Paper No. 7559
Number of pages: 32 Posted: 28 Mar 2019
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 47 (561,891)

Abstract:

Loading...

42.

Has Pharmaceutical Innovation Reduced Social Security Disability Growth?

International Journal of the Economics of Business, Vol. 18, No. 2, pp. 293-316, 2011
Number of pages: 34 Posted: 26 Oct 2011
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 47 (561,891)

Abstract:

Loading...

43.

The Effect of Education on Medical Technology Adoption: Are the More Educated More Likely to Use New Drugs

NBER Working Paper No. w9185
Number of pages: 46 Posted: 14 Sep 2002 Last Revised: 06 Feb 2022
Adriana Lleras-Muney and Frank R. Lichtenberg
Princeton University - Princeton School of Public and International Affairs and Columbia University - Columbia Business School, Finance
Downloads 47 (561,891)

Abstract:

Loading...

Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? a Reexamination Using Data from the U.S. And Australia

NBER Working Paper No. w16051
Number of pages: 19 Posted: 07 Jun 2010 Last Revised: 11 Nov 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 24 (724,534)

Abstract:

Loading...

Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A Reexamination Using Data from the U.S. and Australia

Forum for Health Economics & Policy, Vol. 13, No. 2, p. 11, 2010
Number of pages: 18 Posted: 26 Oct 2011
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 18 (778,183)

Abstract:

Loading...

45.

Government Subsidies to Private Military R&D Investment: Dod's Ir&D Policy

NBER Working Paper No. w2745
Number of pages: 17 Posted: 03 May 2004 Last Revised: 02 Jan 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 42 (587,418)

Abstract:

Loading...

46.

Response to Baker and Fugh-Berman's Critique of My Paper, 'Why Has Longevity Increased More in Some States than in Others?'

CESifo Working Paper Series No. 2712
Number of pages: 16 Posted: 23 Jul 2009
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 37 (615,093)

Abstract:

Loading...

47.

The Effect of Takeovers on the Employment and Wages of Central-Office and Other Personnel

NBER Working Paper No. w2895
Number of pages: 39 Posted: 07 Jul 2004 Last Revised: 01 Jun 2022
Frank R. Lichtenberg and Donald S. Siegel
Columbia University - Columbia Business School, Finance and Arizona State University-School of Public Affairs
Downloads 37 (615,093)
Citation 2

Abstract:

Loading...

48.

Importation and Innovation

NBER Working Paper No. w12539
Number of pages: 25 Posted: 02 Oct 2006 Last Revised: 07 Oct 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 36 (626,789)
Citation 1

Abstract:

Loading...

49.

The Comparative Advantage of Educated Workers in Implementing New Technology: Some Empirical Evidence

NBER Working Paper No. w1718
Number of pages: 33 Posted: 06 Jul 2004 Last Revised: 12 Sep 2022
Ann P. Bartel and Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance and Columbia University - Columbia Business School, Finance
Downloads 33 (638,928)
Citation 6

Abstract:

Loading...

50.

The Health Impact of, and Access to, New Drugs in Korea

East Asian Economic Review, Vol. 24, No. 2 (June 2020)
Number of pages: 38 Posted: 01 Jul 2020
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 32 (645,286)

Abstract:

Loading...

Longevity, Pharmaceutical, Innovation, Korea, Hospitalization, Cancer

51.

The Impact and Organization of Publicly-Funded Research and Development in the European Community

NBER Working Paper No. w6040
Number of pages: 42 Posted: 20 Jun 2000 Last Revised: 04 Jul 2022
Maryann P. Feldman and Frank R. Lichtenberg
University of North Carolina at Chapel Hill and Columbia University - Columbia Business School, Finance
Downloads 32 (645,286)
Citation 2

Abstract:

Loading...

52.

The Effect of New Political Administration on Federal Government Productivity and Employment

NBER Working Paper No. w5601
Number of pages: 15 Posted: 25 Sep 1996 Last Revised: 26 Oct 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 32 (645,286)

Abstract:

Loading...

53.

The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries

NBER Working Paper No. w24536
Number of pages: 46 Posted: 23 Apr 2018 Last Revised: 16 Jan 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 30 (658,600)

Abstract:

Loading...

54.

Private Investment in R&D to Signal Ability to Perform Government Contracts

NBER Working Paper No. w1974
Number of pages: 44 Posted: 25 Jun 2004 Last Revised: 25 Nov 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 30 (665,507)

Abstract:

Loading...

55.

Errors of Measurement in Output Deflators

NBER Working Paper No. w2000
Number of pages: 29 Posted: 22 Apr 2004 Last Revised: 20 Jun 2022
Frank R. Lichtenberg and Zvi Griliches
Columbia University - Columbia Business School, Finance and (Deceased)
Downloads 29 (665,507)

Abstract:

Loading...

56.

The Impact of Increased Utilization of HIV Drugs on Longevity and Medical Expenditures: An Assessment Based on Aggregate U.S. Time-Series Data

NBER Working Paper No. w12406
Number of pages: 30 Posted: 13 Aug 2006 Last Revised: 26 Nov 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 28 (672,550)

Abstract:

Loading...

57.

Have Newer Cardiovascular Drugs Reduced Hospitalization? Evidence from Longitudinal Country-Level Data on 20 OECD Countries, 1995-2003

NBER Working Paper No. w14008
Number of pages: 29 Posted: 16 May 2008 Last Revised: 12 Oct 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 26 (694,847)
Citation 1

Abstract:

Loading...

58.

Pharmaceutical Innovation and the Longevity of Australians: A First Look

NBER Working Paper No. w14009
Number of pages: 23 Posted: 16 May 2008 Last Revised: 13 Oct 2022
Frank R. Lichtenberg and Gautier Duflos
Columbia University - Columbia Business School, Finance and Université Paris I Panthéon-Sorbonne
Downloads 22 (718,564)

Abstract:

Loading...

59.

How Elastic is the Government's Demand for Weapons?

NBER Working Paper No. w3025
Number of pages: 36 Posted: 02 Oct 2007 Last Revised: 09 Oct 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 22 (718,564)

Abstract:

Loading...

60.

The Effect of Pharmaceutical Innovation on the Functional Limitations of Elderly Americans Evidence from the 2004 National Nursing Home Survey

NBER Working Paper No. w17750
Number of pages: 34 Posted: 14 Jan 2012 Last Revised: 03 Jul 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 19 (743,513)

Abstract:

Loading...

61.

How Many Life-Years Have New Drugs Saved? A 3-Way Fixed-Effects Analysis of 66 Diseases in 27 Countries, 2000-2013

NBER Working Paper No. w25483
Number of pages: 35 Posted: 30 Jan 2019 Last Revised: 19 Aug 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 16 (770,005)

Abstract:

Loading...

62.

Labor Market Institutions, Liquidity Constraints, and Macroeconomic Stability

NBER Working Paper No. w3926
Number of pages: 30 Posted: 03 Jul 2007 Last Revised: 25 Sep 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 16 (770,005)

Abstract:

Loading...

63.

The Impact of Therapeutic Procedure Innovation on Hospital Patient Longevity: Evidence from Western Australia, 2000-2007

NBER Working Paper No. w17414
Number of pages: 24 Posted: 21 Sep 2011 Last Revised: 01 Aug 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 15 (779,248)

Abstract:

Loading...

64.

The Effect of Pharmaceutical Innovation on Longevity: Patient-Level Evidence from the 1996-2002 Medical Expenditure Panel Survey and Linked Mortality Public-Use Files

NBER Working Paper No. w18552
Number of pages: 37 Posted: 22 Nov 2012 Last Revised: 11 Sep 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 14 (788,868)
Citation 1

Abstract:

Loading...

65.

Technical Change, Learning, and Wages

NBER Working Paper No. w2732
Number of pages: 26 Posted: 27 Dec 2010 Last Revised: 20 Jun 2022
Ann P. Bartel and Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance and Columbia University - Columbia Business School, Finance
Downloads 13 (798,615)

Abstract:

Loading...

66.

Ir&D Project Data and Theories of R&D Investment

NBER Working Paper No. w2720
Number of pages: 24 Posted: 13 Dec 2010 Last Revised: 09 Jun 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 13 (798,615)

Abstract:

Loading...

67.

The Impact of Biomedical Knowledge Accumulation on Mortality: A Bibliometric Analysis of Cancer Data

NBER Working Paper No. w19593
Number of pages: 34 Posted: 01 Nov 2013 Last Revised: 16 Jul 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 11 (818,724)

Abstract:

Loading...

68.

The Impact of Public and Private Research Support on Premature Cancer Mortality and Hospitalization in the U.S., 1999-2013

NBER Working Paper No. w23241
Number of pages: 24 Posted: 19 Mar 2017 Last Revised: 02 Jan 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 9 (839,751)
Citation 1

Abstract:

Loading...

69.

The Effects of Off-Label Drug Use on Disability and Medical Expenditure

NBER Working Paper No. w30440
Number of pages: 55 Posted: 16 Sep 2022
Katharina Blankart and Frank R. Lichtenberg
University of Duisburg-Essen and Columbia University - Columbia Business School, Finance
Downloads 8 (850,402)

Abstract:

Loading...

70.

The Impact of Pharmaceutical Innovation on Premature Cancer Mortality in Canada, 2000-2011

NBER Working Paper No. w21239
Number of pages: 36 Posted: 08 Jun 2015 Last Revised: 15 Jul 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 8 (850,402)

Abstract:

Loading...

71.

The Long-Run Impact of New Medical Ideas on Cancer Survival and Mortality

NBER Working Paper No. w25328
Number of pages: 36 Posted: 11 Dec 2018 Last Revised: 16 Sep 2022
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 7 (861,511)
Citation 2

Abstract:

Loading...

72.

Listen to Your Doctor, or Else!: Medication Under-Use and Overuse and Long-Term Health Outcomes of Danish Diabetes Patients

NBER Working Paper No. w21780
Number of pages: 34 Posted: 07 Dec 2015 Last Revised: 07 Jul 2022
Gisela Hostenkamp and Frank R. Lichtenberg
University of Southern Denmark and Columbia University - Columbia Business School, Finance
Downloads 6 (872,813)

Abstract:

Loading...

73.

The Impact of Pharmaceutical Innovation on Premature Mortality, Hospital Separations, and Cancer Survival in Australia

Economic Record, Vol. 93, Issue 302, pp. 353-378, 2017
Number of pages: 26 Posted: 11 Sep 2017
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance
Downloads 1 (936,177)

Abstract:

Loading...

74.

Public Policy and Innovation in the U.S. Pharmaceutical Industry

University of Illinois at Urbana-Champaign's Academy for Entrepreneurial Leadership Historical Research Reference in Entrepreneurship
Posted: 04 Nov 2009
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance

Abstract:

Loading...

Imitation, Hatch-Waxman Act of 1984, U.S. Food & Drug Administration (FDA), Kefauver-Harris Amendment of 1962, Prescription Drug User Fee Act of 1992, Medicare, Medicaid, Industrial research, Federal regulations, Product development, Public policies, R&D expenditures, Healthcare industry, Policy analysis, Innovation process, Market value, Patents, Pharmaceutical industry

75.

Pharmaceutical Innovation and Cancer Survival

iHEA 2007 6th World Congress: Explorations in Health Economics Paper
Posted: 28 Jun 2007
Frank R. Lichtenberg, Bengt Jonsson and Nils Wilking
Columbia University - Columbia Business School, Finance, Uppsala University - Department of Information Science and affiliation not provided to SSRN

Abstract:

Loading...

cancer, pharmaceutical, innovation

76.

Hypothesis: The Effect of New Drug Approvals on HIV Mortality in the Us, 1987-1998

Posted: 21 Jul 2003
Frank R. Lichtenberg
Columbia University - Columbia Business School, Finance

Abstract:

Loading...

Health, HIV, mortality, new drug approvals